Skip to main content
SpringerLink
Log in

Depressive Disorders in the Context of HIV/AIDS

Prevalence and Treatment

  • Chapter
Pharmacotherapy of Depression

  • 184 Accesses

Abstract

As of June 2001, an estimated 466,023 persons were living with HIV/AIDS in the United States alone and an estimated 40 million people worldwide (1). It has become increasingly clear that people living with HIV/AIDS confront many challenges in their daily lives (e.g., following a complex medication regimen and facing premature death), some of which are unique to HIV (e.g., coping with stigma and changes in sexuality) (2–6).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Centers for Disease Control and Prevention. U.S. HIV and AIDS cases reported through June 2001. HIV/AIDS Surveillance Rep 2002; 13: 1–41.

    Google Scholar 

  2. Chapman E. Patient impact of negative representations of HIV. AIDS Patient Care STDs 2002; 16: 173–177.

    Article  PubMed  Google Scholar 

  3. Herek GM, Capitanio JP, Widaman KF. HIV-related stigma and knowledge in the United States: prevalence and trends, 1991–1999. Am J Public Health 2002; 92: 371–377.

    Article  PubMed  Google Scholar 

  4. Lester P, Chesney M, Cooke M, et al. Diagnostic disclosure to HIV-infected children: how parents decide when and what to tell. Clin Child Psychol Psychiatry 2002; 7: 85–99.

    Article  Google Scholar 

  5. Lichtenstein B, Laska MK, Clair JM. Chronic sorrow in the HIV-positive patient: issues of race, gender, and social support. AIDS Patient Care STDs 2002; 16: 27–38.

    Article  PubMed  Google Scholar 

  6. Schrimshaw EW, Siegel K. HIV-infected mothers’ disclosure to their uninfected children: rates, reasons, and reactions. J Soc Personal Relationships 2002; 19: 19–44.

    Article  Google Scholar 

  7. Regier DA, Boyd JH, Burke JD. One-month prevalence of mental disorders in the United States: based on five epidemiological catchment area sites. Arch Gen Psychiatry 1988; 45: 977–986.

    Article  PubMed  CAS  Google Scholar 

  8. Kaplan MS, Marks G, Mertens SB. Distress and coping among women with HIV infection: preliminary findings from a multiethnic sample. Am J Orthopsychiatry 1997; 67: 80–91.

    Article  PubMed  CAS  Google Scholar 

  9. Katz MH, Douglas JM, Bolan GA, et al. Depression and use of mental health services among HIV-infected men. AIDS Care 1996; 8: 433–442.

    Article  PubMed  CAS  Google Scholar 

  10. Moneyham L, Sowell R, Seals B, Demi A. Depressive symptoms among African American women with HIV disease. Sch Inq Nurs Pract 2000; 14: 9–39.

    PubMed  CAS  Google Scholar 

  11. Rotheram-Borus MJ, Lightfoot M, Shen H. Levels of emotional distress among parents living with AIDS and their adolescent children. AIDS Behav 1999; 3: 367–372.

    Article  Google Scholar 

  12. Simoni JM, Ng MT. Trauma, coping, and depression among women with HIV/AIDS in New York City. AIDS Care 2000; 12: 567–580.

    Article  PubMed  CAS  Google Scholar 

  13. Johnson JG, Rabkin JG, Lipsitz JD, Williams JBW, Remien RH. Recurrent major depressive disorder among human immunodeficiency virus (HIV)-positive and HIV-negative intravenous drug users: findings of a 3-year longitudinal study. Compr Psychiatry 1999; 40: 31–34.

    Article  PubMed  CAS  Google Scholar 

  14. Jones DJ, Beach SRH, Forehand R, The Family Health Project Research Group. HIV infection and depressive symptoms: an investigation of African American single mothers. AIDS Care 2001; 13: 343–350.

    Article  PubMed  CAS  Google Scholar 

  15. Rabkin JG, Goetz RR, Remien RH, Williams JBW, Todak G, Gorman JM. Stability of mood despite HIV illness progression in a group of homosexual men. Am J Psychiatry 1997; 154: 231–238.

    PubMed  CAS  Google Scholar 

  16. Turrina C, Fiorazzo A, Turano A, et al. Depressive disorders and personality variables in HIV positive and negative intravenous drug users. J Affect Disord 2001; 65: 45–53.

    Article  PubMed  CAS  Google Scholar 

  17. Atkinson JH, Grant I, Kennedy CJ, Richman DD, Spector SA, McCutchan JA. Prevalence of psychiatric disorders among men infected with human immunodeficiency virus. Arch Gen Psychiatry 1988; 45: 852–864.

    Article  Google Scholar 

  18. Dew MA, Becker JT, Sanchez J, et al. Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: a longitudinal evaluation. Psychol Med 1997; 27: 395–409.

    Article  PubMed  CAS  Google Scholar 

  19. Myers HF, Durvasula RS. Psychiatric disorders in African American men and women living with HIV/AIDS. Cultur Divers Ethni Minor Psychol 1999; 5: 249–262.

    Article  Google Scholar 

  20. Perkins DO, Stern RA, Golden RN, Murphy C, Naftolowitz D, Evans DL. Mood disorders in HIV infection: prevalence and risk factors in a non-epicenter of the AIDS epidemic. Am J Psychiatry 1994; 151: 233–236.

    PubMed  CAS  Google Scholar 

  21. Rabkin JG, Ferrando SJ, Jacobsberg LB, Fishman B. Prevalence of axis I disorders in an AIDS cohort: a cross-sectional, controlled study. Compr Psychiatry 1997; 38: 146–154.

    Article  PubMed  CAS  Google Scholar 

  22. Richardson J, Barkan S, Cohen M, et al. Experience and covariates of depressive symptoms among a cohort of HIV infected women. Soc Work Health Care 2001; 32: 93–111.

    Article  PubMed  CAS  Google Scholar 

  23. Grassi L, Mondardini D, Pavanati M, Sighinolfi L, Serra A, Ghinelli F. Suicide probability and psychological morbidity secondary to HIV infection: a control study of HIV-seropositive, hepatitis C virus (HCV)-seropositive and HCV-seronegative injecting drug users. J Affect Disord 2001; 64: 195–202.

    Article  PubMed  CAS  Google Scholar 

  24. Lipsitz JD, Williams JBW, Rabkin, JG et al. Psychopathology in male and female intravenous drug users with and without HIV infection. Am J Psychiatry 1994; 151: 1662–1668.

    PubMed  CAS  Google Scholar 

  25. Malbergier A, De Andrade, AG. Depressive disorders and suicide attempts in injecting drug users with and without HIV infection. AIDS Care 2000; 13: 141–150.

    Article  Google Scholar 

  26. Kelly B, Raphael B, Judd F, et al. Psychiatric disorder in HIV infection. Aust N Z J Psychiatry 1998; 32: 441–453.

    Article  PubMed  CAS  Google Scholar 

  27. Lyketsos CG, Hoover DR, Guccione M, Dew MA, Wesch J, Bing EG, Treisman GJ. Depressive symptoms over the course of HIV infection before AIDS. Soc Psychiatry Psychiatr Epidemiol 1996; 31: 212–219.

    Article  PubMed  CAS  Google Scholar 

  28. Williams JBW, Rabkin JG, Remien RH, Gorman JM, Ehrhardt AA. Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection. II: standardized clinical assessment of current and lifetime psychopathology. Arch Gen Psychiatry 1991; 48: 124–130.

    Article  PubMed  CAS  Google Scholar 

  29. Rabkin JG. Prevalence of psychiatric disorders in HIV illness. Int Rev Psychiatry 1996; 8: 157–166.

    Article  Google Scholar 

  30. Singh N, Squier C, Sivek C, Wagener MM, Yu VL. Psychological stress and depression in older patients with intravenous drug use and human immunodeficiency virus infection: implications for intervention. Int J STD AIDS 1997; 8: 251–255.

    Article  PubMed  CAS  Google Scholar 

  31. Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry 2001; 158: 725–730.

    Article  PubMed  CAS  Google Scholar 

  32. Brechtl JR, Breitbart W, Galietta M, Krivo S, Rosenfeld B. The use of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection: impact on medical, palliative care and quality of life outcomes. J Pain Symptom Manage 2001; 21: 41–51.

    Article  PubMed  CAS  Google Scholar 

  33. Judd FK, Cockram AM, Komiti A, Mijch AM, Hoy J, Bell R. Depressive symptoms reduced in individuals with HIV/AIDS treated with highly active antiretroviral therapy: a longitudinal study. Aust N Z J Psychiatry 2000; 34: 1015–1021.

    Article  PubMed  CAS  Google Scholar 

  34. Low-Beer S, Chan K, Yip B, et al. Depressive symptoms decline among persons on HIV protease inhibitors. J AIDS 2000; 23: 295–301.

    CAS  Google Scholar 

  35. Starace F, Bartoli L, Aloisi MS, et al. Cognitive and affective disorders associated to HIV infection in the HAART era: findings from the NeuroICONA study. Acta Psychiatr Scand 2002; 106: 20–26.

    Article  PubMed  CAS  Google Scholar 

  36. Kalichman SC, Difonzo K, Austin J, Luke W, Rompa D. Prospective study of emotional reactions to changes in HIV viral load. AIDS Patient Care STDs 2002; 16: 113–120.

    Article  PubMed  Google Scholar 

  37. Alciati A, Starace F, Scaramelli B, et al. Has there been a decrease in the prevalence of mood disorders in HIV-seropositive individuals since the introduction of combination therapy? Eur Psychiatry 2001; 16: 491–496.

    Article  PubMed  CAS  Google Scholar 

  38. Rabkin JG, Ferrando SJ, Shu-Hsing L Sewell M, McElhiney M. Psychological effects of HAART: a 2-year study. Psychosom Med 2000; 62: 413–422.

    PubMed  CAS  Google Scholar 

  39. Bing EG, Burnam MA, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry 2001; 58: 721–728.

    Article  PubMed  CAS  Google Scholar 

  40. Heckman TG, Kochman A, Sikkema KJ, Kalichman SC. Depressive symptomatology, daily stressors, and ways of coping among middle-age and older adults living with HIV disease. J Ment Health Aging 1999; 5: 311–322.

    Google Scholar 

  41. Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women. JAMA 2001; 285: 1466–1474.

    Article  PubMed  CAS  Google Scholar 

  42. Jones DJ, Beach SRH, Forehand R, the Family Health Project Research Group. Disease status in African American single mothers with HIV: the role of depressive symptoms. Health Psychol 2001; 20: 417–423.

    Article  PubMed  Google Scholar 

  43. Peterson JL, Folkman S, Bakeman R. Stress, coping, HIV status, psychosocial resources, and depressive mood in African American gay, bisexual, and heterosexual men. Am J Community Psychol 1996; 24: 461–487.

    Article  PubMed  CAS  Google Scholar 

  44. Siegel K, Karus D, Raveis VH. Correlates of change in depressive symptomatology among gay men with AIDS. Health Psychol 1997; 16: 230–238.

    Article  PubMed  CAS  Google Scholar 

  45. Ingram KM, Jones DA, Fass RJ, Neidig JL, Song YS. Social support and unsupportive social interactions: their association with depression among people living with HIV. AIDS Care 1999; 11: 313–329.

    Article  PubMed  CAS  Google Scholar 

  46. Knowlton AR, Latkin CA, Chung S, Hoover DR, Ensminger M, Celentano DD. HIV and depressive symptoms among low-income illicit drug users. AIDS Behav 2000; 4: 353–360.

    Article  Google Scholar 

  47. Lyon DE, Younger JB. Purpose in life and depressive symptoms in persons living with HIV disease. J Nurs Scholarsh 2001; 33: 129–133.

    Article  PubMed  CAS  Google Scholar 

  48. Johnson JG, Alloy LB, Panzarella C, et al. Hopelessness as a mediator of the association between social support and depressive symptoms: findings of a study of men with HIV. J Consult Clin Psychol 2001; 69: 1056–1060.

    Article  PubMed  CAS  Google Scholar 

  49. Savetsky JB, Sullivan LM, Clarke J, Stein MD, Samet JH. Evolution of depressive symptoms in human immunodeficiency virus-infected patients entering primary care. J Nerv Ment Dis 2001; 189: 76–83.

    Article  PubMed  CAS  Google Scholar 

  50. Cohen M, Hoffman RG, Cromwell C, et al. The prevalence of distress in persons with human immunodeficiency virus infection. Psychosomatics 2002; 43: 10–15.

    Article  PubMed  Google Scholar 

  51. Vedhara K, Schifitto G, McDermott M, for the Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders. Disease progression in HIV-positive women with moderate to severe immunosuppression: the role of depression. Behav Med 1999; 25: 43–47.

    Article  Google Scholar 

  52. Chandra PS, Ravi V, Desai A, Subbakrishna DK. Anxiety and depression among HIV-infected heterosexuals: a report from India. J Psychosom Res 1998; 45: 401–409.

    Article  PubMed  CAS  Google Scholar 

  53. Balderson K, Halman M, Jones K. Psychiatric aspects of HIV disease. Prim Care Psychiatry 2000; 6: 83–92.

    Article  Google Scholar 

  54. Mellins CA, Ehrhardt AA, Grant WF. Psychiatric symptomatology and psychological functioning in HIV-infected mothers. AIDS Behav 1997; 1: 233–245.

    Article  Google Scholar 

  55. Judd F, Mijch A, McCausland J, Cockram A. Depressive symptoms in patients with HIV infection: a further exploration. Aust N Z J Psychiatry 1997; 31: 862–868.

    Article  PubMed  CAS  Google Scholar 

  56. Rabkin JG, Ferrando SJ, van Gorp W, Rieppi R, McElhiney M, Sewell M. Relationships among apathy, depression, and cognitive impairment in HIV/AIDS. J Neuropsychiatry Clin Neurosci 2000; 12: 451–457.

    Article  PubMed  CAS  Google Scholar 

  57. Semple SJ, Patterson TL, Shaw WS, et al. HIV-seropositive parents: parental role strain and depressive symptoms. AIDS Behav 1997; 1: 213–224.

    Article  Google Scholar 

  58. van Servellen G, Aguirre M, Sarna L, Brecht M. Differential predictors of emotional distress in HIV-infected men and women. West J Nurs Res 2002; 24: 49–72.

    PubMed  Google Scholar 

  59. Nolen-Hoeksema S. Gender differences in depression. Curr Dir Psychol Sci 2001; 10: 173–176.

    Article  Google Scholar 

  60. Kalichman SC, Rompa D, Cage M. Distinguishing between overlapping somatic symptoms of depression and HIV disease in people living with HIV-AIDS. J Nerv Ment Dis 2000; 188: 662–670.

    Article  PubMed  CAS  Google Scholar 

  61. Savard J, Laberge B, Gauthier JG, Ivers H, Bergeron MG. Evaluating anxiety and depression in HIV-infected patients. J Pers Assess 1998; 71: 349–367.

    Article  PubMed  CAS  Google Scholar 

  62. Cohen MH, French AL, Benning L, Kovacs A, Anastos MY, Young, M et al. Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy. Am J Med 2002; 113: 91–98.

    Article  PubMed  Google Scholar 

  63. Lyketsos CG, Hoover DR, Guccione M. Depression and survival among HIV-infected persons [letter]. JAMA 1996; 275: 35–36.

    Article  PubMed  CAS  Google Scholar 

  64. Gordillo V, del Amo J, Soriano V, Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 1999; 13: 1763–1769.

    Article  PubMed  CAS  Google Scholar 

  65. van Servellen G, Sarna L, Nyamathi A, Padilla G, Brecht M, Jablonski KJ. Emotional distress in women with asymptomatic HIV disease. Issues Ment Health Nursing 1998; 19: 173–189.

    Article  CAS  Google Scholar 

  66. Lyketsos CG, Treisman GJ. Mood disorders in HIV infection. Psychiatr Ann 2001; 31: 45–49.

    Google Scholar 

  67. McDaniels JS, Chung JY, Brown L, et al. Practice guideline for the treatment of patients with HIV/AIDS. Am J Psychiatry 2000; 157 (Suppl): 1–62.

    Google Scholar 

  68. Gillenwater DR, McDaniel JS. Rational psychopharmacology for patients with HIV infection and AIDS. Psychiatr Ann 2001; 31: 28–34.

    Google Scholar 

  69. Elliott AJ, Russo J, Bergam K, Claypoole K, Uldall KK, Roy-Byrne PP. Antidepressant efficacy in HIV-seropositive outpatients with Major Depressive Disorder: an open trial of nefazodone. J Clin Psychiatry 1999; 60: 226–231.

    Article  PubMed  CAS  Google Scholar 

  70. Schwartz AJ, McDaniel JS. Double-blind comparison of fluoxetine and desipramine in the treatment of depressed women with advanced HIV disease: a pilot study. Depress Anxiety 1999; 9: 70–74.

    Article  PubMed  CAS  Google Scholar 

  71. Elliott AJ, Uldall KK, Bergam K, Russo J, Claypoole K, Roy-Byrne PP. Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients. Am J Psychiatry 1998; 155: 367–372.

    PubMed  CAS  Google Scholar 

  72. Stober DR, Schwartz JAJ, McDaniel JS, Abrams RF. Depression and HIV disease: prevalence, correlates, and treatment. Psychiatric Annals 1997; 27: 372–377.

    Google Scholar 

  73. Ferrando S Wagner GJ, Rabkin R. Effects of dextroamphetamine on depression and fatigue in men with HIV: a double-blind, placebo-controlled trial. J Clin Psychiatry 2000; 61: 436–440.

    Article  Google Scholar 

  74. Blanch J, Rousaud A, Hautzinger M, et al. Assessment of the efficacy of a cognitive-behavioural group psychotherapy programme for HIV-infected patients referred to a consultation-liaison psychiatry department. Psychother Psychosom 2002; 71: 77–84.

    Article  PubMed  Google Scholar 

  75. Lutgendorf SK, Antoni MH, Ironson G, et al. Cognitive-behavioral stress management decreases dysphoric mood and herpes simplex virus-type 2 antibody titers in symptomatic HIVseropositive gay men. J Consult Clin Psychol 1997; 65: 31–43.

    Article  PubMed  CAS  Google Scholar 

  76. Inouye J, Flannelly L, Flannelly KJ. The effectiveness of self-management training for individuals with HIV/AIDS. J Assoc Nurses AIDS Care 2001; 12: 71–82.

    Article  PubMed  CAS  Google Scholar 

  77. Pomeroy EC, Kiam R, Abel EM. The effectiveness of a psychoeducational group for HIVinfected/affected incarcerated women. Res Soc Work Pract 1999; 9: 171–187.

    Article  Google Scholar 

  78. Pomeroy EC, Rubin A, Laningham LV, Walker RJ. “Straight Talk”: the effectiveness of a psychoeducational group intervention for heterosexuals with HIV/AIDS. Res Soc Work Pract 1997; 7: 149–164.

    Google Scholar 

  79. Eller, L. Effects of two cognitive-behavioral interventions on immunity and symptoms in persons with HIV. Ann Behav Med 1995; 17: 339–348.

    Article  Google Scholar 

  80. Targ E, Karasic D, Diefenbach P, Anderson D, Bystritsky A, Fawzy F. Structured group therapy and fluoxetine to treat depression in HIV-positive persons. Psychosomatics 1994; 35: 132–137.

    Article  PubMed  CAS  Google Scholar 

  81. Markowitz JC, Kocsis JH, Fishman B, et al. Treatment of depressive symptoms in human immunodeficiency virus-positive patients. Arch Gen Psychiatry 1998; 55: 452–457.

    Article  PubMed  CAS  Google Scholar 

  82. Markowitz JC, Spielman LA, Sullivan M, Fishman B. An exploratory study of ethnicity and psychotherapy outcome among HIV-positive patients with depressive symptoms. J Psychother Pract Res 2000; 9: 226–231.

    PubMed  CAS  Google Scholar 

  83. Avants SK, Margolin A, DePhilippis D, Kosten TR. A comprehensive pharmacologic-psychosocial treatment program for HIV-seropositive cocaine-and opioid-dependent patients: preliminary findings. J Subst Abuse Treat 1998; 15: 261–265.

    Article  PubMed  CAS  Google Scholar 

  84. Lee MR, Cohen L, Hadley SW, Goodwin FK. Cognitive-behavioral group therapy with medication for depressed gay men with AIDS or symptomatic HIV infection. Psychiatr Serv 1999; 50: 948–952.

    PubMed  CAS  Google Scholar 

  85. Zisook S, Peterkin J, Goggin KJ, Sledge P, Atkinson JH, Grant I. Treatment of major depression in HIV-seropositive men. J Clin Psychiatry 1998; 59: 217–224.

    Article  PubMed  CAS  Google Scholar 

  86. Savard J, Laberge B, Gauthier JG, et al. Combination of fluoxetine and cognitive therapy for the treatment of major depression among people with HIV infection: a time-series analysis investigation. Cogn Ther Res 1998; 22: 21–46.

    Article  Google Scholar 

  87. Siegel K, Karus D, Raveis VH, Hagen D. Psychological adjustment of women with HIV/ AIDS: racial and ethnic comparisons. J Community Psychol 1998; 26: 439–455.

    Article  Google Scholar 

  88. Savard J, Laberge B, Gauthier JG, Bergeron MG. Screening clinical depression in HIVseropositive patients using the hospital anxiety and depression scale. AIDS Behav 1999; 3: 167–175.

    Article  Google Scholar 

Download references

Authors
  1. Jori A. Berger-Greenstein PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen Brady PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David Spiggle MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Deborah J. Brief PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Terence M. Keane PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Psychiatry, Boston University School of Medicine, Boston, MA, USA

    Domenic A. Ciraulo MD

  2. Division of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Boston, MA, USA

    Richard I. Shader MD

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media New York

About this chapter

Cite this chapter

Berger-Greenstein, J.A., Brady, S., Spiggle, D., Brief, D.J., Keane, T.M. (2004). Depressive Disorders in the Context of HIV/AIDS. In: Ciraulo, D.A., Shader, R.I. (eds) Pharmacotherapy of Depression. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-792-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-792-5_7

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-6172-6

  • Online ISBN: 978-1-59259-792-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation